|
|
Neurology September 2009
Volume 73
Issue 13
| This week in Neurology(R) |
this week in neurology(r): highlights of the september 29 issue.
Pages: 1005
|
| Editorials |
transcranial sonography of deep gray nuclei: a new outcome measure in multiple sclerosis?.
- Pirko, Istvan, Zivadinov, Robert, MD, PhD. Pages: 1006-1007
|
beyond hippocampal sclerosis: the rewired hippocampus in temporal lobe epilepsy.
- Madden, Megan, Sutula, Thomas, MD, PhD. Pages: 1008-1009
|
| Articles |
transcranial brain sonography findings predict disease progression in multiple sclerosis.
- Walter, U, Wagner, S, Horowski, S, Benecke, R, Zettl, U. Pages: 1010-1017
>
Show/Hide Abstract
Objective: In multiple sclerosis (MS), an early neurodegenerative affection of subcortical gray matter has been suggested. Transcranial sonography (TCS) shows hyperechogenic lesions of substantia nigra (SN) and basal ganglia, thought to reflect iron accumulation, in a number of primary neurodegenerative diseases. The present study deals with the question of whether TCS can also display deep gray matter lesions in patients with MS and whether sonographic findings relate to severity and progression of MS.Methods: We prospectively studied 75 patients with different courses of MS and 55 age-matched healthy subjects clinically and with TCS. Twenty-three patients additionally had 1.5-T MRI at the time of TCS. Disease progression was assessed clinically 2 years after TCS.Results: Abnormal hyperechogenicity of SN, lenticular nucleus (LN), caudate nucleus, and thalamus was found in 41%, 54%, 40%, and 8% of the patients with MS, with similar frequency in patients with relapsing-remitting and primary or secondary progressive MS if corrected for disease duration, but only in 13%, 13%, 5% (each, p < 0.001), and none (p = 0.028) of the control subjects. Hyperechogenicity of SN and LN correlated with more pronounced MRI T2 hypointensity, thought to reflect iron deposition. Larger bilateral SN echogenic area was related to higher rate of disease progression, whereas small SN echogenic area (SN hypoechogenicity) predicted a disease course without further progression within 2 years.Conclusions: Neurodegenerative disease-like deep gray matter lesions can be frequently detected by transcranial sonography (TCS) in patients with multiple sclerosis (MS). Findings suggest that TCS shows changes of brain iron metabolism which correlate with future progress of MS.(C)2009AAN Enterprises, Inc.
|
apolipoprotein genotype does not influence ms severity, cognition, or brain atrophy.
- van der Walt, A, Stankovich, J, Bahlo, M, Taylor, B, van der Mei, I, Foote, S, Kilpatrick, T, Rubio, J, Butzkueven, H. Pages: 1018-1025
>
Show/Hide Abstract
Background: The influence of APOE allelic heterogeneity on multiple sclerosis (MS) disease severity has been reported in multiple datasets with conflicting results. Several studies have reported an unfavorable association of APOE [epsilon]4 with more severe clinical disease course while, in contrast, APOE [epsilon]2 has been associated with a more benign disease course. In this study, we examine the influence of heterogeneity of the APOE gene on disease severity in a large, Australian, population-based MS cohort.Methods: Associations between APOE allele status, 2 promoter region single nucleotide polymorphisms (-219 G/T and +113 C/G), and 4 measures of disease severity were tested in 1,006 patients with relapsing-remitting MS and secondary progressive MS: 1) Multiple Sclerosis Severity Score; 2) Progression Index (Expanded Disability Status Scale/disease duration); 3) age at first symptom; and 4) interval between the first and second attack. The Symbol Digit Modalities Test was used as a single cognitive marker in 889 patients. Brain atrophy was measured in 792 patients using the intercaudate ratio. APOE [epsilon]4 and [epsilon]3 carriers were stratified by -219 G/T or +113 C/G to investigate haplotypic heterogeneity in the APOE gene region.Results: In this MS study, neither APOE allele status nor promoter region heterogeneity at positions -219 G/T or +113 C/G influenced the clinical disease severity, cognition, or cerebral atrophy.Conclusions: Allelic and haplotypic heterogeneity of the APOE gene region does not influence multiple sclerosis disease course in this well-defined Australian multiple sclerosis cohort.(C)2009AAN Enterprises, Inc.
|
increased neuronal proliferation in human bacterial meningitis.
- Gerber, J, Tauber, S, Armbrecht, I, Schmidt, H, Bruck, W, Nau, R. Pages: 1026-1032
>
Show/Hide Abstract
Objective: Neurogenesis is increased in experimental models of bacterial meningitis. In this study, neurogenesis was examined after bacterial infection of the CNS, and after stroke and brain trauma in humans.Methods: Brain sections of patients after death from bacterial meningitis, stroke, or brain trauma and from autopsy cases after death from nonneurologic diseases were investigated by immunohistochemistry.Results: In the dentate gyrus, the density of proliferating cellular nuclear antigen-expressing cells was higher after bacterial meningitis compared to the control group (p = 0.0075). Furthermore, the number of cells expressing the immature neuronal marker proteins TUC-4 and doublecortin were increased in brain sections of patients after death from meningitis compared to control cases (p = 0.0067 and p = 0.045). After stroke and brain trauma, higher densities of proliferating cells were observed (p = 0.031 and p = 0.018), while an increase of TUC-4-expressing cells was detected after stroke only (p = 0.0012 and p = 0.47).Conclusions: The increased proliferation of neural progenitors suggests an endogenous mechanism in response to noxious stimuli. Stimulation of neurogenesis might help to alleviate the consequences of neuronal destruction in bacterial meningitis and other diseases of the brain.(C)2009AAN Enterprises, Inc.
|
bilateral reorganization of the dentate gyrus in hippocampal sclerosis: a postmortem study.
- Thom, M, Martinian, L, Catarino, C, Yogarajah, M, Koepp, M, Caboclo, L, Sisodiya, S. Pages: 1033-1040
>
Show/Hide Abstract
Background: Hippocampal sclerosis (HS) is the most common surgical pathology associated with mesial temporal lobe epilepsy (MTLE). HS is typically characterized by mossy fiber sprouting (MFS) and reorganization of neuropeptide Y (NPY) fiber networks in the dentate gyrus. One potential cause of postoperative seizure recurrence following temporal lobe surgery may be the presence of seizure-associated bilateral hippocampal damage. We aimed to investigate patterns of hippocampal abnormalities in a postmortem series as identified by NPY and dynorphin immunohistochemistry.Methods: Analysis of dentate gyrus fiber reorganization, using dynorphin (to demonstrate MFS) and NPY immunohistochemistry, was carried out in a postmortem epilepsy series of 25 cases (age range 21-96 years). In 9 patients, previously refractory seizures had become well controlled for up to 34 years prior to death.Results: Bilateral MFS or abnormal NPY patterns were seen in 15 patients including those with bilateral symmetric, asymmetric, and unilateral HS by conventional histologic criteria. MFS and NPY reorganization was present in all classical HS cases, more variably in atypical HS, present in both MTLE and non-MTLE syndromes and with seizure histories of up to 92 years, despite seizure remission in some patients.Conclusion: Synaptic reorganization in the dentate gyrus may be a bilateral, persistent process in epilepsy. It is unlikely to be sufficient to generate seizures and more likely to represent a seizure-induced phenomenon.(C)2009AAN Enterprises, Inc.
|
juvenile myoclonic epilepsy 25 years after seizure onset: a population-based study .
- Camfield, Carol, MD, FRCP, Camfield, Peter, MD, FRCP. Pages: 1041-1045
>
Show/Hide Abstract
Objective: To document the long-term evolution of juvenile myoclonic epilepsy (JME) in a population-based cohort.Methods: All patients developing JME by 16 years of age in Nova Scotia between 1977 and 1985 were contacted in 2006-2008.Results: Twenty-four patients (17 women) had JME, 3.5% of all childhood-onset epilepsy. Age at first seizure was 10.4 +/- 4.3 years. We contacted 23 of 24 (96%) at a mean age of 36 +/- 4.8 years. All were initially treated with antiepileptic drugs (AEDs). At the end of a 25.8 +/- 2.4-year follow-up, 11 (48%) had discontinued treatment: 6 were seizure-free (without AEDs for 5-23 years), 3 had myoclonic seizures only (without AEDs for >18 years), and 2 continued with rare seizures. Convulsive status epilepticus occurred in 8 (36%) and 3 had intractable epilepsy. About 70% reported good satisfaction with their health, work, friendships, and social life (Likert scales). Despite 87% high school graduation, 31% were unemployed. Sixteen live with a partner, 7 alone. Nine received antidepressant medications. Ten women had >=1 pregnancy and 4 men fathered a child. Eleven pregnancies (80%) were unplanned, outside of a stable relationship. At least 1 major unfavorable social outcome was noted in 76%.Conclusions: Our sample size is modest but the long follow-up and population-based sampling is unique. All seizure types in juvenile myoclonic epilepsy (JME) resolved in 17% and for 13%, only myoclonus persisted. Therefore, one-third of people with JME have troublesome seizures vanish and antiepileptic drug treatment is no longer needed. Depression, social isolation, unemployment, and social impulsiveness complicate the lives of many patients.(C)2009AAN Enterprises, Inc.
|
de novo mutations of voltage-gated sodium channel [alpha]ii gene scn2a in intractable epilepsies.
- Ogiwara, I, Ito, K, Sawaishi, Y, MD, PhD, Osaka, H, MD, PhD, Mazaki, E, Inoue, I, Montal, M, MD, PhD, Hashikawa, T, Shike, T, Fujiwara, T, MD, PhD, Inoue, Y, MD, PhD, Kaneda, M, MD, PhD, Yamakawa, K. Pages: 1046-1053
>
Show/Hide Abstract
Background: Mutations of voltage-gated sodium channel [alpha]II gene, SCN2A, have been described in a wide spectrum of epilepsies. While inherited SCN2A mutations have been identified in multiple mild epilepsy cases, a de novo SCN2A-R102X mutation, which we previously reported in a patient with sporadic intractable childhood localization-related epilepsy, remains unique. To validate the involvement of de novo SCN2A mutations in the etiology of intractable epilepsies, we sought to identify additional instances.Methods: We performed mutational analyses on SCN2A in 116 patients with severe myoclonic epilepsy in infancy, infantile spasms, and other types of intractable childhood partial and generalized epilepsies and did whole-cell patch-clamp recordings on Nav1.2 channels containing identified mutations.Results: We discovered 2 additional de novo SCN2A mutations. One mutation, SCN2A-E1211K, was identified in a patient with sporadic infantile spasms. SCN2A-E1211K produced channels with altered electrophysiologic properties compatible with both augmented (a ~18-mV hyperpolarizing shift in the voltage dependence of activation) and reduced (a ~22-mV hyperpolarizing shift in the voltage dependence of steady-state inactivation and a slowed recovery from inactivation) channel activities. The other de novo mutation, SCN2A-I1473M, was identified in a patient with sporadic neonatal epileptic encephalopathy. SCN2A-I1473M caused a ~14-mV hyperpolarizing shift in the voltage dependence of activation.Conclusions: The identified de novo mutations SCN2A-E1211K, -I1473M, and -R102X indicate that SCN2A is an etiologic candidate underlying a variety of intractable childhood epilepsies. The phenotypic variations among patients might be due to the different electrophysiologic properties of mutant channels.(C)2009AAN Enterprises, Inc.
|
three-dimensional mr volumetric analysis of the posterior fossa csf space in hemifacial spasm.
- Chan, L, Ng, K, Fook-Chong, S, Lo, Y, Tan, E. Pages: 1054-1057
>
Show/Hide Abstract
Background: We hypothesize that a smaller posterior fossa (PF) CSF space may be a risk factor for hemifacial spasm (HFS).Objective: We conducted a case-control 3-dimensional magnetic resonance (MR) volumetric study in patients with HFS and determined the clinical predictive factors of PF CSF volume.Methods: Patients with clinically diagnosed HFS and controls matched for age, sex, race, and hypertension underwent MRI/magnetic resonance angiography examination. The PF CSF space was segmented and quantified on a heavily T2-weighted high-resolution 3-dimensional MR volume slab, centered over the porus acusticus.Results: Eighty-two study subjects (41 patients and 41 controls) were included. The mean PF CSF volume in patients with HFS and controls was 17,303.0 +/- 3,900.0 vs 19,216.0 +/- 3,912.0 mm3. The mean volume in patients with HFS was 11.4% smaller than in controls (p = 0.015). Analysis of differences between individually matched pairs and controls also revealed that PF CSF for controls was larger than that for patients with HFS (p = 0.007). A multivariate linear regression analysis revealed that a small PF CSF volume was associated with HFS (p = 0.01). Decreasing age (p = 0.001) and female gender (p < 0.0005), but not hypertension (p = 0.892), were also found to be predictors of a low PF CSF volume.Conclusions: Our results showed that the posterior fossa (PF) CSF volume was lower in patients with HFS compared with matched controls. HFS, female gender, and younger age were associated with smaller PF CSF volume. These observations could explain the strong female preponderance in both clinic- and population-based epidemiologic studies.(C)2009AAN Enterprises, Inc.
|
atrophy patterns in ivs10+16, ivs10+3, n279k, s305n, p301l, and v337m mapt mutations.
- Whitwell, J, Jack, C, Boeve, B, Senjem, M, Baker, M, Ivnik, R, Knopman, D, Wszolek, Z, Petersen, R, MD, PhD, Rademakers, R, Josephs, K, MST, MD. Pages: 1058-1065
>
Show/Hide Abstract
Objective: To use a case-control study to assess and compare patterns of gray matter loss across groups of subjects with different mutations in the microtubule-associated protein tau (MAPT) gene.Methods: We identified all subjects from Mayo Clinic, Rochester, Minnesota, that screened positive for mutations in MAPT and had a head MRI (n = 22). Voxel-based morphometry was used to assess patterns of gray matter atrophy in groups of subjects with the IVS10+16, IVS10+3, N279K, S305N, P301L, and V337M mutations compared with age- and sex-matched controls.Results: All MAPT groups showed gray matter loss in the anterior temporal lobes, with varying degrees of involvement of the frontal and parietal lobes. Within the temporal lobe, the subjects with IVS10+16, IVS10+3, N279K, and S305N mutations (mutations that influence the alternative splicing of tau pre-messenger RNA) all showed gray matter loss focused on the medial temporal lobes. In contrast to these groups, the subjects with P301L or V337M mutations (mutations that affect the structure of the tau protein) both showed gray matter loss focused on the lateral temporal lobes, with a relative sparing of the medial temporal lobe.Conclusion: There seem to be differences in patterns of temporal lobe atrophy across the MAPT mutations, which may aid in the differentiation of the different mutation carriers. Furthermore, there seems to be a possible association between mutation function and pattern of temporal lobe atrophy.(C)2009AAN Enterprises, Inc.
|
good clinical outcome after ischemic stroke with successful revascularization is time-dependent .
- Khatri, P, Abruzzo, T, Yeatts, S, Nichols, C, Broderick, J, Tomsick, T. Pages: 1066-1072
>
Show/Hide Abstract
Background: Trials of IV recombinant tissue plasminogen activator (rt-PA) have demonstrated that longer times from ischemic stroke symptom onset to initiation of treatment are associated with progressively lower likelihoods of clinical benefit, and likely no benefit beyond 4.5 hours. How the timing of IV rt-PA initiation relates to timing of restoration of blood flow has been unclear. An understanding of the relationship between timing of angiographic reperfusion and clinical outcome is needed to establish time parameters for intraarterial (IA) therapies.Methods: The Interventional Management of Stroke pilot trials tested combined IV/IA therapy for moderate-to-severe ischemic strokes within 3 hours from symptom onset. To isolate the effect of time to angiographic reperfusion on clinical outcome, we analyzed only middle cerebral artery and distal internal carotid artery occlusions with successful reperfusion (Thrombolysis in Cerebral Infarction 2-3) during the interventional procedure (<7 hours). Time to angiographic reperfusion was defined as time from stroke onset to procedure termination. Good clinical outcome was defined as modified Rankin Score 0-2 at 3 months.Results: Among the 54 cases, only time to angiographic reperfusion and age independently predicted good clinical outcome after angiographic reperfusion. The probability of good clinical outcome decreased as time to angiographic reperfusion increased (unadjusted p = 0.02, adjusted p = 0.01) and approached that of cases without angiographic reperfusion within 7 hours.Conclusions: We provide evidence that good clinical outcome following angiographically successful reperfusion is significantly time-dependent. At later times, angiographic reperfusion may be associated with a poor risk-benefit ratio in unselected patients.(C)2009AAN Enterprises, Inc.
|
| Clinical/Scientific Notes |
characterizing radiology reports in patients with frontotemporal dementia.
- Suarez, J, Tartaglia, M, Vitali, P, Erbetta, A, Neuhaus, J, Laluz, V, Miller, B. Pages: 1073-1074
|
most stroke patients do not get a warning: a population-based cohort study.
- Hackam, D, MD, PhD, Kapral, M, MD, MSc, Wang, J, Fang, J, Hachinski, V, MD, DSc. Pages: 1074-1076
|
| Resident & Fellow Section |
child neurology: dravet syndrome: when to suspect the diagnosis.
- Millichap, John, Koh, Sookyong, MD, PhD, Laux, Linda, Nordli, Douglas. Pages: e59-e62
>
Show/Hide Abstract
Dravet syndrome (DS), previously known as severe myoclonic epilepsy in infancy (SMEI), is an epileptic encephalopathy that presents with prolonged seizures in the first year of life. The seizures often occur with fever or illness, and are frequently initially categorized as febrile seizures. The correct diagnosis of DS and appropriate follow-up are typically delayed. The EEG is normal at onset, and neuroimaging reveals no structural lesion. Early development is normal, but signs of regression appear in the second year of life and are often accompanied by convulsive status epilepticus, alternating hemiconvulsions, and myoclonic seizures. Diagnosis can be confirmed by genetic testing that is now available, and shows mutations within the SCN1A gene. Early recognition and diagnosis of DS and management with appropriate anticonvulsants and treatment plan may reduce the seizure burden and improve long-term developmental outcome.(C)2009AAN Enterprises, Inc.
|
teaching neuroimages: artery-to-artery embolism from a thrombosed cerebral aneurysm.
- Ha, S, Park, K, Youn, Y, MD, PhD, Seo, H, Kwon, O, MD, PhD. Pages: e63
|
| Patient Page |
juvenile myoclonic epilepsy, a common epilepsy syndrome.
- Karceski, Steven. Pages: e64-e67
|
| Correspondence |
intravenous immunoglobulin in relapsing-remitting multiple sclerosis: a dose-finding trial.
- Engel, W. Pages: 1077-1078
|
combining beta interferon and atorvastatin may increase disease activity in multiple sclerosis.
- Salvatore, Elena, Morra, Vincenzo, Orefice, Giuseppe. Pages: 1078-1079
|
| Departments: Books Received |
books received.
Pages: 1080-1081
|
| Departments: Calendar |
calendar.
Pages: 1082
|
| Future Issues |
in the next issue of neurology(r): volume 73, number 14, october 6, 2009.
Pages: A34
|
|
|